Vanguard Personalized Indexing Management, LLC Lyell Immunopharma, Inc. Transaction History

Vanguard Personalized Indexing Management, LLC

$6.09 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.3 - $3.01 $2,993 - $6,932	2,303 Added 14.06%	18,682 $27,000
Q1 2024 May 09, 2024	BUY	$1.71 - $3.07 $790 - $1,418	462 Added 2.9%	16,379 $36,000
Q4 2023 Feb 07, 2024	BUY	$1.39 - $2.35 $22,124 - $37,404	15,917 New	15,917 $30,000

Others Institutions Holding LYEL

# of Institutions

121

Shares Held

142M

Call Options Held

18.1K

Put Options Held

200

Mwg Management Ltd. Washington, DC

20.2M
Shares

$12.3 Million
30.81% of portfolio
Apoletto LTD Washington, DC

15.1M
Shares

$9.21 Million
42.56% of portfolio
Orland Properties LTD Washington, DC

15.1M
Shares

$9.21 Million
13.96% of portfolio
Black Rock Inc. New York, NY

13.5M
Shares

$8.23 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$6.14 Million
0.0% of portfolio

View Full List

About Lyell Immunopharma, Inc.

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $151M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

More about LYEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account